The Latest In Neo-Adjuvant Therapy For Luminal Breast Cancer

The latest in neo-adjuvant therapy for luminal breast cancer

Neoadjuvant hormonal treatment for luminal breast cancer: rationale, evidence and outcome

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

Preoperative management of operable cT3 cN1 luminal breast cancer: Upfront neoadjuvant chemotherapy

Is chemotherapy only a treatment of last resort in luminal breast cancers?

ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer

Adjuvant Therapy | 2023 Best of Breast Conference

Total Health | Oncology

Neoadjuvant Therapy for HR+ Breast Cancer

Intensified dosing of neoadjuvant Foxy-5 for colon cancer in the NeoFox trial

Neoadjuvant treatment approach for HER2 positive breast cancer

OncBrothers: Practice-Changing Cancer Discussions

Chemotherapy in patients with luminal breast cancer and an intermediate risk recurrence score

Breast Cancer Neoadjuvant Chemotherapy: For Patients

Breast Cancer School for Patients

Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers

Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

Highlights on omitting radiotherapy after surgery for luminal A Breast Cancer: The LUMINA Trial

European Society for Medical Oncology (ESMO)

Utilizing neoadjuvant immunotherapies in patients with ER+, HER2- primary breast cancer

How to use Neoadjuvant Therapies in Breast Cancer?

European Society for Medical Oncology (ESMO)

The role of immunotherapy in endocrine-refractory luminal breast cancer